The Global Healthcare Innovation Alliance Accelerator (GHIAA)
Policy to Impact
GHIAA creates resources, curates information, collaborates with stakeholders and provides consulting support related to policies and agreement provisions that aim to achieve equitable, global access to medical products.
Our Work
MAPGuideⓇ Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuideⓇ Platform
The MAPGuideⓇ platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products.
Resources on the platform include our Provision Database, Equitable Access Toolkit, and Equitable Access Glossary.
Access MAPGuideⓇ Platform
Consulting Services
Expert advice for access plans, provisions and policies
Consulting Services
We have substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of developing and implementing access plans and agreement provisions.
Find out more
Strategic Insights
For new vaccine manufacturing
initiatives
initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
MAPGuideⓇ Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuideⓇ Platform
The MAPGuideⓇ platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products.
Resources on the platform include our Provision Database, Equitable Access Toolkit, and Equitable Access Glossary.
Access MAPGuideⓇ Platform
Consulting Services
Expert advice for access plans, provisions and policies
Consulting Services
We have substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of developing and implementing access plans and agreement provisions.
Find out more
Strategic Insights
For new vaccine manufacturing initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
MAPGuideⓇ Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuideⓇ Platform
The MAPGuideⓇ platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products.
Resources on the platform include our Provision Database, Equitable Access Toolkit, and Equitable Access Glossary.
Access MAPGuideⓇ Platform
Consulting Services
Expert advice for access plans, provisions and policies
Consulting Services
We have substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of developing and implementing access plans and agreement provisions.
Find out more
Strategic Insights
For new vaccine manufacturing
initiatives
initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
Latest News
- October 28, 2024
Julie Barnes-Weise Moderates Panel and LES Annual Meeting
Julie moderated a workshop at the Licensing Executives Society (LES) USA & Canada Annual Meeting on Monday, October 21, 2024 titled "Bridging the Gap – Licensing Medical Technologies for Innovation and Global Equitable Access." Of the event, Julie said, “The LES Annual Meeting was a great opportunity to meet up with colleagues and to meet new people in the licensing community. Our panel members included some of the most experienced professionals in the field of global health focused agreements and we had a very productive discussion which clearly illustrated the need for all of the different types of organizations to work together to ensure that products reach all patient populations in need of them. Audience members asked us thoughtful questions about how the different types of agreements would work for their organizations.” Materials available to attendees here - September 10, 2024
GHIAA Participates in Multi-Continent Vaccinology Course
GHIAA Executive Director Julie Barnes-Weise participated in the 23rd Annual International Vaccinology Course (IVC) hosted by the International Vaccine Institute (IVI). Held from September 2-6, the intensive institute explored the full spectrum of vaccine development, testing, regulation, approval, and administration. The IVC is hosted annually at IVI’s headquarters in Seoul, Republic of Korea. This year, the course was also held simultaneously at two additional locations: Stockholm, Sweden, and Kigali, Rwanda, where IVI’s Europe Regional Office and Africa Regional Office are located. Learn more about the program here - August 30, 2024
WHO Pandemic Agreement: Recommendations for INB 11
Ahead of INB 11, GHIAA has published its comments and recommendations on the latest proposed text for the WHO Pandemic Agreement. Read the commentary. - July 13, 2024
GHIAA calls for CSO Access to Pandemic Agreement Negotiations
Along with 140 supporters form 40 different countries, GHIAA has signed on to Pandemic Action Network’s Partner Call for Action. The open letter demands the official inclusion of civil society organizations (CSOs) in the INB Pandemic Agreement negotiation process Read the full letter and sign here.